Cargando…
A modeling informed quantitative approach to salvage clinical trials interrupted due to COVID‐19
Many ongoing Alzheimer's disease central nervous system clinical trials are being disrupted and halted due to the COVID‐19 pandemic. They are often of a long duration’ are very complex; and involve many stakeholders, not only the scientists and regulators but also the patients and their family...
Autores principales: | Geerts, Hugo, van der Graaf, Piet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606183/ https://www.ncbi.nlm.nih.gov/pubmed/33163611 http://dx.doi.org/10.1002/trc2.12053 |
Ejemplares similares
-
Salvaging CNS Clinical Trials Halted Due to COVID‐19
por: Geerts, Hugo, et al.
Publicado: (2020) -
Model‐informed target identification and validation through combining quantitative systems pharmacology with network‐based analysis
por: Chelliah, Vijayalakshmi, et al.
Publicado: (2022) -
Learn–confirm in model‐informed drug development: Assessing an immunogenicity quantitative systems pharmacology platform
por: Franssen, Linnea C., et al.
Publicado: (2022) -
Application of quantitative systems pharmacology to guide the optimal dosing of COVID‐19 vaccines
por: Giorgi, Mario, et al.
Publicado: (2021) -
Computational Approaches for Supporting Combination Therapy in the Post-Aducanumab Era in Alzheimer’s Disease
por: Geerts, Hugo, et al.
Publicado: (2021)